S. Yılmaz Et Al. , "Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease," 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya , 2016
Yılmaz, S. Et Al. 2016. Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease. 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya .
Yılmaz, S., Oran, İ., Şen, F., Akboğa, M., ARAS, D., TEMİZHAN, A., ... AYDOĞDU, S.(2016). Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease . 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya
Yılmaz, Samet Et Al. "Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease," 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya, 2016
Yılmaz, Samet Et Al. "Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease." 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya , 2016
Yılmaz, S. Et Al. (2016) . "Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease." 32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya .
@conferencepaper{conferencepaper, author={Samet Yılmaz Et Al. }, title={Serum fibrinogen level predicts long term adverse events in patients who underwent percutaneous coronary intervention for saphenous venous graft disease}, congress name={32. Uluslararası katılımlı Türk kardiyoloji Kongresi, 20-23 Ekim 2016, Antalya}, city={}, country={}, year={2016}}